|
| Wednesday, February 15, 2023 |
|
|
Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital |
| Legend Capital invested in 29 healthcare companies that officially disclosed financing rounds in 2022, according to the VBDATA Database. more info >> |
|
| Thursday, December 15, 2022 |
|
|
Legend Capital Portfolio Company Bespin Global Completes USD100m Series D Financing |
| Legend Capital Portfolio Company Bespin Global, a Korea-headquartered cloud services company, has recently completed its Series D round financing of USD100 million, which will be used mostly for acquisitions. more info >> |
|
| Friday, December 9, 2022 |
|
|
Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing |
| Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as "GS Biotech") officially announced the completion of its nearly CNY100 million pre-A round financing, led by Legend Capital. more info >> |
|
| Sunday, November 13, 2022 |
|
|
Legend Capital Portfolio Company Atour Successfully Lists on Nasdaq |
| On the evening of November 11, Beijing time, Legend Capital portfolio company Atour Lifestyle Holdings Limited ("Atour") was officially listed on the Nasdaq Stock Exchange in the United States. It has priced its initial public offering of 4,750,000 American Depositary Shares ("ADSs") at US$11.0 per ADS. more info >> |
|
| Thursday, November 10, 2022 |
|
|
Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round |
| Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital. more info >> |
|
| Monday, November 7, 2022 |
|
|
Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX |
| On November 4, 2022, Legend Capital portfolio company Giant Biogene (2367.HK) was successfully listed on the main board of the Hong Kong Stock Exchange. more info >> |
|
| Tuesday, November 1, 2022 |
|
|
Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round |
| Recently, the healthcare big data leader ClinBrain completed the Series C round of financing of nearly CNY200 million, led by Legend Capital. more info >> |
|
|
Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round |
| Shanghai Easy-Flow ("Easy-Flow") recently completed its Angel financing round by raising tens of millions of CNY, led by Legend Capital. The fresh capital will be used for the R&D of Easy-Flow's peripheral intervention pipeline. more info >> |
|
| Thursday, October 20, 2022 |
|
|
Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round |
| VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as "VectorBuilder"), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital. more info >> |
|
| Sunday, September 25, 2022 |
|
|
GalaxySpace Completes a New Financing Round with Legend Capital Re-upped |
| GalaxySpace, a Chinese commercial aerospace company, recently completed its latest financing round with a post-investment valuation of approximately RMB11 billion. more info >> |
|
|
|
